Balto Pharmaceuticals
PrivateLast Round
Seed
Aug 30, 2023
Total Funding Raised
$2M
Company Overview
Balto Pharmaceuticals is a biotechnology company that develops small molecule inhibitors targeting protein-protein interactions for the treatment of cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Balto Pharmaceuticals Comparables
Compare Balto Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SyntheX | 85% | |
| Ambagon Therapeutics | 85% | |
| Magnet Biomedicine | 85% | |
Balto Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 30, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2023
$2M round completed.
Balto Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Balto Pharmaceuticals's valuation, stock price, and market status.